相关实验视频

Updated: Sep 16, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

TMprss6通过肝素轴和PI3K/AKT通路调节辐射诱导的肝损伤

Ya-Li Zhou^1,2, Zhen-Xin Wang³, Jia-Qin Gao^1,2

¹MOE Engineering Center of Hematological Disease, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.

International journal of radiation biology

|July 10, 2025

概括

马特里酶2 (Tmprss6) 缺乏会通过增加亡和炎症,使辐射诱导的肝损伤 (RILI) 恶化. 准PI3K-AKT通路可能会减轻RILI的进展.

科学领域:

肝病学肝病学是一种肝病学.
辐射瘤学辐射瘤学
分子生物学分子生物学

背景情况:

辐射诱导性肝损伤 (RILI) 是癌症放射治疗中的一个重大临床挑战.
正常的肝脏组织受到腹部和盆腔放射治疗的不利影响.

研究的目的:

调查Tmprss6 (马特里普塔2) 在急性RILI中的作用.
了解Tmprss6对肝细胞亡和RILI进展的影响.

主要方法:

建立了一个RILI小鼠模型,使用30 Gy的肝脏总辐射.
使用Tmprss6淘汰赛小鼠来评估RILI的严重程度.
采用免疫组织化学,西部斑块,qPCR和转录组学进行分子分析.
使用AKT抑制剂AZD5363.3进行了体外实验.

主要成果:

Tmprss6淘汰赛加剧了RILI,降低了生存率并增加了肝损伤.
辐射破坏了Matriptase2-hepcidin轴,降低了Tmprss6并增加了hepcidin.
删除tmprss6增加了炎症性细胞因子,MDA和p53,同时降低了抗氧化能力.
AKT抑制剂AZD5363逆转了Tmprss6沉默诱导的亡和p53上调.

结论:

缺少Tmprss6会放大p53的表达,促进肝细胞亡和RILI.
PI3K-AKT信号通路部分调解了Tmprss6在RILI中的保护作用.
这些发现为Tmprss6在RILI病原发生中的作用提供了机理性的见解.

关键词:

这就是PI3K-AKTT.时间prss6 灭症 (apoptosis) 是一种死亡的过程.辐射引起的肝损伤.

更多相关视频

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice

Published on: March 10, 2017

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...